2004
DOI: 10.1128/aac.48.8.2831-2837.2004
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro Activities of ME1036 (CP5609), a Novel Parenteral Carbapenem, against Methicillin-Resistant Staphylococci

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
25
0

Year Published

2005
2005
2013
2013

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 40 publications
(27 citation statements)
references
References 19 publications
2
25
0
Order By: Relevance
“…3 For the study reported herein, ME1036 was found to have potent anitbacterial activity against genotypic PRSPs (gPRSPs) that are resistant to b-lactams due to mutated pbps. In particular, the strong binding affinities of antibiotics for PBP1A, PBP2X and PBP2B from gPRSP is thought to be basis for its strong antibacterial activities.…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…3 For the study reported herein, ME1036 was found to have potent anitbacterial activity against genotypic PRSPs (gPRSPs) that are resistant to b-lactams due to mutated pbps. In particular, the strong binding affinities of antibiotics for PBP1A, PBP2X and PBP2B from gPRSP is thought to be basis for its strong antibacterial activities.…”
Section: Discussionmentioning
confidence: 93%
“…ME1036 ( Figure 1) is a new broad-spectrum parenteral carbapenem that is active against multi-drug resistant Gram-positive and Gramnegative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum b-lactamase-producing Enterobacteriaceae. 3 The study reported herein was designed to evaluate the relationship between the binding affinities of ME1036 for wild-type and mutant penicillin-binding proteins (PBPs) and its efficacy against S. pneumoniae strains containing those PBPs.…”
Section: The Emergence Of Penicillin-intermediate and Penicillin-resimentioning
confidence: 99%
“…Instead of increasing the angular strain and the N1 pyramidality (''twisted amide'') in the azetidinone ring of 1,4-fused bi- [64,65] or tricyclic systems [66], we considered flexible 1,3-bridged bicyclic systems featuring a ''planar amide'' and a large ring susceptible to generate a lot of conformers. Such azetidinones, endowed with a thienamycin-like side-chain at C3 and the related stereochemistry at C3-C5, are readily accessible via a convergent RCM strategy, as illustrated by the synthesis of the 13-membered bicycles E-11 and 12 from the commercial chiron 7, precursor of 10.…”
Section: Discussionmentioning
confidence: 99%
“…Particularly, the prevalence of MRSA (methicillin-resistant Staphylococcus aureus) in hospitals has stimulated the development of more potent carbapenems (ME 1036 [64]) and cephalosporins (PPI 0903M [65]), characterized by very bulky substituents on the bicyclic skeletons. The lethal action of such antibiotics is due to their high affinity for PBP 2a .…”
Section: Discussionmentioning
confidence: 99%
“…ME1036, a novel parenteral carbapenem, was developed to combat MRSA or VISA [3][4], and it is expected to be useful for the treatment of severe staphylococcal infections such as pneumonia, bacteremia, and pulmonary abscesses.…”
Section: Introductionmentioning
confidence: 99%